-+ 0.00%
-+ 0.00%
-+ 0.00%

Kymera Therapeutics Price Target Raised to $134.00/Share From $84.00 by HC Wainwright & Co.

Dow Jones·12/09/2025 15:37:00

登錄查看新聞詳情